Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | S501_A502insSAY |
Impact List | insertion |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | KIT S501_A502insSAY results in an insertion of three amino acids in the Ig-like C2-type 5 domain (exon 9) of the Kit protein between amino acids 501 and 502 (UniProt.org). S501_A502insSAY has not been characterized, however similar Kit exon 9 mutations are activating (PMID: 22324351), and therefore, is predicted to lead to a gain of Kit protein function. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT S501_A502insSAY KIT mutant KIT exon9 KIT exon 9 ins KIT S501_A502insSAY |
Transcript | NM_000222.3 |
gDNA | chr4:g.54726013_54726014insAGCGCATAT |
cDNA | c.1503_1504insAGCGCATAT |
Protein | p.S501_A502insSAY |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000222.3 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
NM_001385286.1 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
NM_001093772 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
XM_017008180 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
NM_001093772.1 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
XM_017008180.1 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54726013_54726014insAGCGCATAT | c.1503_1504insAGCGCATAT | p.S501_A502insSAY | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|